HIV-1 Tat and AIDS-associated cancer: Targeting the cellular anti-cancer barrier?

Journal of Experimental and Clinical Cancer Research

Volumn 27, Issue 1, 2008, Pages

  Nunnari, Giuseppe ^a   Smith, Johanna A ^b   Daniel, René ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS 1 PROTEIN TAT; TAT INTERACTIVE PROTEIN 60; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CARCINOGENESIS; DNA REPAIR; DOUBLE STRANDED DNA BREAK; GENOMIC INSTABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; BIOLOGICAL MODEL; GENETICS; METABOLISM; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; MODELS, BIOLOGICAL; NEOPLASMS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 53149105513     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-27-3     Document Type: Review

References (99)

1. Targeted inhibition of angiogenic factors in AIDS-related disorders. Y Aoki G Tosato, Current Drug Targets - Infectious Disorders 2003 3 115 128 10.2174/1568005033481222
2. Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma (KS): implications for the design of therapeutic trials in patients with advanced symptomatic KS.[comment]. G Nasti U Tirelli, Journal of Clinical Oncology 2005 23 2433 author reply 2433-2434. 10.1200/JCO.2005.05.790 15800341
3. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients.[comment]. JA Ambroziak DJ Blackbourn BG Herndier RG Glogau JH Gullett AR McDonald ET Lennette JA Levy, Science 1995 268 582 583 10.1126/science. 7725108 7725108
4. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.[see comment]. Y Chang E Cesarman MS Pessin F Lee J Culpepper DM Knowles PS Moore, Science 1994 266 1865 1869 10.1126/science.7997879 7997879
5. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. R Renne M Lagunoff W Zhong D Ganem, Journal of Virology 1996 70 8151 8154 8892944
6. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. M Schalling M Ekman EE Kaaya A Linde P Biberfeld, Nature Medicine 1995 1 707 708 10.1038/nm0795-707 7585156
7. Detection of human herpesvirus 8 DNA in Kaposi's sarcoma lesions and peripheral blood of human immunodeficiency virus-positive patients and correlation with serologic measurements. MS Smith C Bloomer R Horvat E Goldstein JM Casparian B Chandran, Journal of Infectious Diseases 1997 176 84 93 9207353
8. Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat. HG Guo S Pati M Sadowska M Charurat M Reitz, Journal of Virology 2004 78 9336 9342 15308728 10.1128/JVI.78.17.9336-9342.2004
9. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. B Ensoli L Buonaguro G Barillari V Fiorelli R Gendelman RA Morgan P Wingfield RC Gallo, Journal of Virology 1993 67 277 287 8416373
10. Perspective on Kaposi's sarcoma: facts, concepts, and conjectures. MS Reitz Jr LS Nerurkar RC Gallo, Journal of the National Cancer Institute 1999 91 1453 1458 10.1093/jnci/91.17.1453 10469745
11. HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. A Vendeville F Rayne A Bonhoure N Bettache P Montcourrier B Beaumelle, Molecular Biology of the Cell 2004 15 2347 2360 15020715 10.1091/mbc.E03-12-0921
12. Neoplastic conditions in the context of HIV-1 infection. Y Aoki G Tosato, Current HIV Research 2004 2 343 349 10.2174/1570162043351002 15544455
13. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. B Ensoli G Barillari SZ Salahuddin RC Gallo F Wong-Staal, Nature 1990 345 84 86 10.1038/345084a0 2184372
14. HIV-1 Tat protein and endothelium: from protein/cell interaction to AIDS-associated pathologies. M Rusnati M Presta, Angiogenesis 2002 5 141 151 10.1023/A:1023892223074 12831055
15. Addressing controversies over Kaposi's sarcoma.[comment]. R Weiss C Boshoff, Journal of the National Cancer Institute 2000 92 677 679 10.1093/jnci/92.9.677 10793096
16. Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer. B Clarke R Chetty, Molecular Pathology 2002 55 19 24 11836442 10.1136/mp.55.1.19
17. Colonic adenocarcinoma associated with the acquired immune deficiency syndrome. MS Cappell F Yao KC Cho, Cancer 1988 62 616 619 10.1002/1097- 0142(19880801)62:3〈616::AID-CNCR2820620329〉3.0.CO;2-J 3390798
18. HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data. CD Cooksley LY Hwang DK Waller CE Ford, International Journal of STD & AIDS 1999 10 795 802 10.1258/0956462991913574 10639060
19. Cancer incidence in New York State acquired immunodeficiency syndrome patients. B Gallagher Z Wang MJ Schymura A Kahn EJ Fordyce, American Journal of Epidemiology 2001 154 544 556 10.1093/aje/154.6.544 11549560
20. Colon adenocarcinoma in HIV infection: a case report and review. AD Klugman J Schaffner, American Journal of Gastroenterology 1994 89 254 256 8304313
21. Gastrointestinal neoplasia in young HIV antibody-positive patients. S Ravalli AB Chabon AA Khan, American Journal of Clinical Pathology 1989 91 458 461 2929501
22. Colorectal malignancies in HIV-positive patients. JF Yeguez SA Martinez DR Sands LR Sands MD Hellinger, American Surgeon 2003 69 981 987 14627261
23. Oncogenic properties of HIV-Tat in colorectal cancer cells. D Huynh E Vincan T Mantamadiotis D Purcell CK Chan R Ramsay, Current HIV Research 2007 5 403 409 10.2174/157016207781023974 17627503
24. The DNA damage response: putting checkpoints in perspective. BB Zhou SJ Elledge, Nature 2000 408 433 439 10.1038/35044005 11100718
25. The role of DNA single- and double-strand breaks in cell killing by ionizing radiation. PL Olive, Radiation Research 1998 150 S42 51 10.2307/3579807 9806608
26. Lethality induced by a single site-specific double-strand break in a dispensable yeast plasmid. CB Bennett AL Lewis KK Baldwin MA Resnick, Proceedings of the National Academy of Sciences of the United States of America 1993 90 5613 5617 8516308 10.1073/pnas.90.12.5613
27. Induction of dominant lethality by x-rays in radiosensitive strain of yeast. KS Ho RK Mortimer, Mutation Research 1973 20 45 51 4586554
28. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. J Falck J Coates SP Jackson, Nature 2005 434 605 611 10.1038/nature03442 15758953
29. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex.[see comment][erratum appears in Science. 2005 Jun 24;308(5730):1870]. JH Lee TT Paull, Science 2005 308 551 554 10.1126/science.1108297 15790808
30. Distinct roles of two separable in vitro activities of yeast Mre11 in mitotic and meiotic recombination. M Furuse Y Nagase H Tsubouchi K Murakami-Murofushi T Shibata K Ohta, EMBO Journal 1998 17 6412 6425 9799249 10.1093/emboj/17.21.6412
31. The many interfaces of Mre11. JE Haber, Cell 1998 95 583 586 10.1016/S0092-8674(00)81626-8 9845359
32. The 3' to 5' exonuclease activity of Mre 11 facilitates repair of DNA double-strand breaks. TT Paull M Gellert, Molecular Cell 1998 1 969 979 10.1016/S1097-2765(00)80097-0 9651580
33. Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex. TT Paull M Gellert, Genes & Development 1999 13 1276 1288 10346816 10.1101/gad.13.10.1276
34. Complex formation and functional versatility of Mre11 of budding yeast in recombination. T Usui T Ohta H Oshiumi J Tomizawa H Ogawa T Ogawa, Cell 1998 95 705 716 10.1016/S0092-8674(00)81640-2 9845372
35. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. A Jazayeri J Falck C Lukas J Bartek GC Smith J Lukas SP Jackson, Nature Cell Biology 2006 8 37 45 10.1038/ncb1337 16327781
36. ATR and ATRIP: partners in checkpoint signaling. D Cortez S Guntuku J Qin SJ Elledge, Science 2001 294 1713 1716 10.1126/science.1065521 11721054
37. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes.[see comment]. L Zou SJ Elledge, Science 2003 300 1542 1548 10.1126/science.1083430 12791985
38. ATM regulates ATR chromatin loading in response to DNA double-strand breaks. M Cuadrado B Martinez-Pastor M Murga LI Toledo P Gutierrez-Martinez E Lopez O Fernandez-Capetillo, Journal of Experimental Medicine 2006 203 297 303 16461339 10.1084/jem.20051923
39. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation.[see comment]. CJ Bakkenist MB Kastan, Nature 2003 421 499 506 10.1038/nature01368 12556884
40. ATM and ATR: networking cellular responses to DNA damage. Y Shiloh, Current Opinion in Genetics & Development 2001 11 71 77 10.1016/S0959- 437X(00)00159-3 11163154
41. The life and death of DNA-PK. SJ Collis TL DeWeese PA Jeggo AR Parker, Oncogene 2005 24 949 961 10.1038/sj.onc.1208332 15592499
42. DNA-dependent protein kinase (Ku protein-p350 complex) assembles on double-stranded DNA. A Suwa M Hirakata Y Takeda SA Jesch T Mimori JA Hardin, Proceedings of the National Academy of Sciences of the United States of America 1994 91 6904 6908 8041718 10.1073/pnas.91.15.6904
43. Mechanisms of eukaryotic DNA double strand break repair. D Cahill B Connor JP Carney, Frontiers in Bioscience 2006 11 1958 1976 10.2741/1938 16368571
44. Non-homologous DNA end joining. E Pastwa J Blasiak, Acta Biochimica Polonica 2003 50 891 908 14739985
45. ATR-dependent radiation-induced gamma H2AX foci in bystander primary human astrocytes and glioma cells. S Burdak-Rothkamm SC Short M Folkard K Rothkamm KM Prise, Oncogene 2007 26 993 1002 10.1038/sj.onc.1209863 16909103
46. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. S Burma BP Chen M Murphy A Kurimasa DJ Chen, Journal of Biological Chemistry 2001 276 42462 42467 10.1074/jbc.C100466200 11571274
47. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.[see comment]. D Cortez Y Wang J Qin SJ Elledge, Science 1999 286 1162 1166 10.1126/science.286.5442.1162 10550055
48. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1.[see comment]. O Fernandez-Capetillo HT Chen A Celeste I Ward PJ Romanienko JC Morales K Naka Z Xia RD Camerini-Otero N Motoyama, Nature Cell Biology 2002 4 993 997 10.1038/ncb884 12447390
49. Role for ATM in DNA damage-induced phosphorylation of BRCA1. M Gatei SP Scott I Filippovitch N Soronika MF Lavin B Weber KK Khanna, Cancer Research 2000 60 3299 3304 10866324
50. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. RS Tibbetts D Cortez KM Brumbaugh R Scully D Livingston SJ Elledge RT Abraham, Genes & Development 2000 14 2989 3002 11114888 10.1101/gad.851000
51. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. IM Ward J Chen, Journal of Biological Chemistry 2001 276 47759 47762 10.1074/jbc.M009785200 11673449
52. Megabase chromatin domains involved in DNA double-strand breaks in vivo. EP Rogakou C Boon C Redon WM Bonner, Journal of Cell Biology 1999 146 905 916 10477747 10.1083/jcb.146.5.905
53. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. EP Rogakou DR Pilch AH Orr VS Ivanova WM Bonner, Journal of Biological Chemistry 1998 273 5858 5868 10.1074/jbc.273.10.5858 9488723
54. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. TT Paull EP Rogakou V Yamazaki CU Kirchgessner M Gellert WM Bonner, Current Biology 2000 10 886 895 10.1016/S0960-9822(00)00610-2 10959836
55. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. DS Lim ST Kim B Xu RS Maser J Lin JH Petrini MB Kastan, Nature 2000 404 613 617 10.1038/35007091 10766245
56. ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response.[see comment]. X Wu V Ranganathan DS Weisman WF Heine DN Ciccone TB O'Neill KE Crick KA Pierce WS Lane G Rathbun, Nature 2000 405 477 482 10.1038/35013089 10839545
57. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products.[see comment]. S Zhao YC Weng SS Yuan YT Lin HC Hsu SC Lin E Gerbino MH Song MZ Zdzienicka RA Gatti, Nature 2000 405 473 477 10.1038/35013083 10839544
58. ATM-dependent phosphorylation of nibrin in response to radiation exposure. M Gatei D Young KM Cerosaletti A Desai-Mehta K Spring S Kozlov MF Lavin RA Gatti P Concannon K Khanna, Nature Genetics 2000 25 115 119 10.1038/75508 10802669
59. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. M O'Driscoll VL Ruiz-Perez CG Woods PA Jeggo JA Goodship, Nature Genetics 2003 33 497 501 10.1038/ng1129 12640452
60. Homologous and non-homologous recombination differentially affect DNA damage repair in mice. J Essers H van Steeg J de Wit SM Swagemakers M Vermeij JH Hoeijmakers R Kanaar, EMBO Journal 2000 19 1703 1710 10747037 10.1093/emboj/19.7.1703
61. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. M Takata MS Sasaki E Sonoda C Morrison M Hashimoto H Utsumi Y Yamaguchi-Iwai A Shinohara S Takeda, EMBO Journal 1998 17 5497 5508 9736627 10.1093/emboj/17.18.5497
62. Evidence for DNA-PK-dependent and -independent DNA double-strand break repair pathways in mammalian cells as a function of the cell cycle. SE Lee RA Mitchell A Cheng EA Hendrickson, Molecular & Cellular Biology 1997 17 1425 1433
63. Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV. SE Critchlow RP Bowater SP Jackson, Current Biology 1997 7 588 598 10.1016/S0960-9822(06)00258-2 9259561
64. Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells.[see comment]. U Grawunder M Wilm X Wu P Kulesza TE Wilson M Mann MR Lieber, Nature 1997 388 492 495 10.1038/41358 9242410
65. Phosphorylation of linker histones by DNA-dependent protein kinase is required for DNA ligase IV-dependent ligation in the presence of histone H1. B Kysela M Chovanec PA Jeggo, Proceedings of the National Academy of Sciences of the United States of America 2005 102 1877 1882 15671175 10.1073/pnas.0401179102
66. Artemis links ATM to double strand break rejoining. PA Jeggo M Lobrich, Cell Cycle 2005 4 359 362 15684609
67. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. E Riballo M Kuhne N Rief A Doherty GC Smith MJ Recio C Reis K Dahm A Fricke A Krempler, Molecular Cell 2004 16 715 724 10.1016/j.molcel.2004.10.029 15574327
68. DNA damage tumor suppressor genes and genomic instability. N Motoyama K Naka, Current Opinion in Genetics & Development 2004 14 11 16 10.1016/j.gde.2003.12.003 15108799
69. ATM signaling and genomic stability in response to DNA damage. MF Lavin G Birrell P Chen S Kozlov S Scott N Gueven, Mutation Research 2005 569 123 132 15603757
70. Genetic epidemiology of BRCA1. FJ Couch, Cancer Biology & Therapy 2004 3 509 514 15254414
71. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. A Celeste S Difilippantonio MJ Difilippantonio O Fernandez-Capetillo DR Pilch OA Sedelnikova M Eckhaus T Ried WM Bonner A Nussenzweig, Cell 2003 114 371 383 10.1016/S0092-8674(03)00567-1 12914701
72. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.[see comment]. J Bartkova Z Horejsi K Koed A Kramer F Tort K Zieger P Guldberg M Sehested JM Nesland C Lukas, Nature 2005 434 864 870 10.1038/nature03482 15829956
73. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.[see comment]. VG Gorgoulis LV Vassiliou P Karakaidos P Zacharatos A Kotsinas T Liloglou M Venere RA Ditullio Jr NG Kastrinakis B Levy, Nature 2005 434 907 913 10.1038/nature03485 15829965
74. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. C Zhu MA Bogue DS Lim P Hasty DB Roth, Cell 1996 86 379 389 10.1016/S0092-8674(00)80111-7 8756720
75. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development.[see comment]. Y Gao DO Ferguson W Xie JP Manis J Sekiguchi KM Frank J Chaudhuri J Horner RA DePinho FW Alt, Nature 2000 404 897 900 10.1038/35009138 10786799
76. Analysis of ku80-mutant mice and cells with deficient levels of p53. DS Lim H Vogel DM Willerford AT Sands KA Platt P Hasty, Molecular & Cellular Biology 2000 20 3772 3780 10.1128/MCB.20.11.3772-3780.2000
77. Tat as a transcriptional activator and a potential therapeutic target for HIV-1. A Gatignol KT Jeang, Advances in Pharmacology 2000 48 209 227 10987092
78. Regulation of Cellular Gene Expression and Function by the Human Immunodeficiency Virus Type 1 Tat Protein. HK Chang RC Gallo B Ensoli, Journal of Biomedical Science 1995 2 189 202 10.1007/BF02253380 11725056
79. Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine. RC Gallo, Proceedings of the National Academy of Sciences of the United States of America 1999 96 8324 8326 10411869 10.1073/pnas.96.15.8324
80. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. MO Westendorp R Frank C Ochsenbauer K Stricker J Dhein H Walczak KM Debatin PH Krammer, Nature 1995 375 497 500 10.1038/375497a0 7539892
81. From the outside in: extracellular activities of HIV Tat. D Noonan A Albini, Advances in Pharmacology 2000 48 229 250 10987093
82. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. JN Sarkaria EC Busby RS Tibbetts P Roos Y Taya LM Karnitz RT Abraham, Cancer Research 1999 59 4375 4382 10485486
83. The HIV-1 Tat nuclear localization sequence confers novel nuclear import properties. A Efthymiadis LJ Briggs DA Jans, Journal of Biological Chemistry 1998 273 1623 1628 10.1074/jbc.273.3.1623 9430704
84. The HIV-1 transactivator protein Tat is a potent inducer of the human DNA repair enzyme beta-polymerase. DK Srivastava CL Tendler D Milani MA English JD Licht SH Wilson, AIDS 2001 15 433 440 10.1097/00002030-200103090-00001 11242139
85. HIV-1 Tat increases cell survival in response to cisplatin by stimulating Rad51 gene expression. G Chipitsyna D Slonina K Siddiqui F Peruzzi T Skorski K Reiss BE Sawaya K Khalili S Amini, Oncogene 2004 23 2664 2671 10.1038/sj.onc.1207417 14755242
86. HIV-1 Tat depresses DNA-PK(CS) expression and DNA repair, and sensitizes cells to ionizing radiation. Y Sun YC Huang QZ Xu HP Wang B Bai JL Sui PK Zhou, International Journal of Radiation Oncology, Biology, Physics 2006 65 842 850 16751065
87. Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator. J Kamine B Elangovan T Subramanian D Coleman G Chinnadurai, Virology 1996 216 357 366 10.1006/viro.1996.0071 8607265
88. A large-scale RNAi screen in human cells identifies new components of the p53 pathway.[see comment]. K Berns EM Hijmans J Mullenders TR Brummelkamp A Velds M Heimerikx RM Kerkhoven M Madiredjo W Nijkamp B Weigelt, Nature 2004 428 431 437 10.1038/nature02371 15042092
89. HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses. E Col C Caron C Chable-Bessia G Legube S Gazzeri Y Komatsu M Yoshida M Benkirane D Trouche S Khochbin, EMBO Journal 2005 24 2634 2645 16001085 10.1038/sj.emboj.7600734
90. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. T Ikura VV Ogryzko M Grigoriev R Groisman J Wang M Horikoshi R Scully J Qin Y Nakatani, Cell 2000 102 463 473 10.1016/S0092-8674(00)00051-9 10966108
91. Tip60 is targeted to proteasome-mediated degradation by Mdm2 and accumulates after UV irradiation. G Legube LK Linares C Lemercier M Scheffner S Khochbin D Trouche, EMBO Journal 2002 21 1704 1712 11927554 10.1093/emboj/21.7. 1704
92. Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks.[see comment]. R Murr JI Loizou YG Yang C Cuenin H Li ZQ Wang Z Herceg, Nature Cell Biology 2006 8 91 99 10.1038/ncb1343 16341205
93. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Y Sun X Jiang S Chen N Fernandes BD Price, Proceedings of the National Academy of Sciences of the United States of America 2005 102 13182 13187 16141325 10.1073/pnas.0504211102
94. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis.[see comment]. Y Tang J Luo W Zhang W Gu, Molecular Cell 2006 24 827 839 10.1016/j.molcel.2006.11.021 17189186
95. Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response. C Gorrini M Squatrito C Luise N Syed D Perna L Wark F Martinato D Sardella A Verrecchia S Bennett, Nature 2007 448 1063 1067 10.1038/nature06055 17728759
96. Tip60 acetylates six lysines of a specific class in core histones in vitro. A Kimura M Horikoshi, Genes to Cells 1998 3 789 800 10.1046/j.1365-2443. 1998.00229.x 10096020
97. The highly conserved and multifunctional NuA4 HAT complex. Y Doyon J Cote, Current Opinion in Genetics & Development 2004 14 147 154 10.1016/j.gde.2004.02.009 15196461
98. Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions. T Kusch L Florens WH Macdonald SK Swanson RL Glaser JR Yates 3rd SM Abmayr MP Washburn JL Workman, Science 2004 306 2084 2087 10.1126/science.1103455 15528408
99. Control of the histone-acetyltransferase activity of Tip60 by the HIV-1 transactivator protein, Tat. M Creaven F Hans V Mutskov E Col C Caron S Dimitrov S Khochbin, Biochemistry 1999 38 8826 8830 10.1021/bi9907274 10393559